PDS Biotechnology Corporation
NASDAQ:PDSB
3.28 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -42.942 | -40.855 | -16.918 | -14.847 | -6.999 | -40.868 | -50.86 | -38.821 | -28.079 | -12.201 | -6.883 |
| Depreciation & Amortization
| 0.057 | 0 | 0.005 | 0.016 | 0.098 | 0.174 | 0.183 | 0.1 | 0.053 | 0.031 | 0.004 |
| Deferred Income Tax
| -1.965 | 0 | 0 | 0 | -0.382 | 2.823 | 0.141 | 0.269 | 0.199 | 0.035 | 0 |
| Stock Based Compensation
| 0.008 | 5.196 | 4.11 | 0.452 | 3.176 | 7.615 | 6.4 | 5.305 | 2.899 | 1.298 | 0.26 |
| Change In Working Capital
| -0.199 | 4.475 | 0.076 | 1.07 | -4.605 | -3.428 | 3.074 | 0.782 | 1.256 | 1.698 | -2.281 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 5.764 | -0.09 | -0.106 | 0.218 | -1.978 | -3.97 | 0.898 | 1.421 | -0.072 | 0.527 | -1.661 |
| Other Working Capital
| -5.963 | 4.565 | 0.182 | 0.852 | -2.627 | 0.541 | 2.176 | -0.638 | 1.328 | 1.171 | -0.62 |
| Other Non Cash Items
| 3.799 | 5.474 | 0.241 | 0.161 | -9.363 | 0.532 | 0.364 | 0.176 | 1.918 | -0.576 | 0.854 |
| Operating Cash Flow
| -33.636 | -25.71 | -12.486 | -13.149 | -18.073 | -33.153 | -40.697 | -32.189 | -21.753 | -9.715 | -8.045 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0 | 0 | 0 | 0 | 0 | 0 | -0.189 | -0.687 | -1.305 | -0.885 | -0.137 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 29.107 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0.275 | 0 | 0 | -0.687 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 29.382 | 0 | -0.189 | -0.687 | -1.305 | -0.885 | -0.137 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.059 | -0.449 | 0 | 0 | 0 | -20.99 | -5 | -1.489 | -0.534 | 0 | -0.022 |
| Common Stock Issued
| 16.436 | 9.856 | 48.889 | 29.757 | 0.75 | 1.513 | 17.383 | -0.23 | 86.059 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.016 | 24.881 | 0.049 | 0.07 | 0.001 | 0.721 | 5.171 | 10.573 | 53.993 | 16.471 | 15.921 |
| Financing Cash Flow
| 16.376 | 34.287 | 48.889 | 29.827 | 0.75 | -20.269 | 22.554 | 9.085 | 139.518 | 16.471 | 15.899 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -17.26 | 8.578 | 36.403 | 16.678 | 12.058 | -53.422 | -18.331 | -23.791 | 116.46 | 5.871 | 7.717 |
| Cash At End Of Period
| 56.561 | 73.82 | 65.243 | 28.84 | 12.162 | 34.646 | 88.068 | 106.399 | 130.189 | 13.729 | 7.858 |